Caring for survivors of breast cancer: Perspective of the primary care physician

Current Oncology

Volumn 18, Issue 5, 2011, Pages

  Smith, S L ^a,b   Wai, E S ^a,b   Alexander, C ^c   Singh Carlson, S ^d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Vancouver Island Cancer Centre   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Breast cancer survivors; Follow up cancer care; Primary care physician perspective; Survivorship care plans

Indexed keywords

ACCESS TO INFORMATION; ANXIETY; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVOR; CLINICAL COMPETENCE; CONTINUING EDUCATION; CONTROLLED STUDY; FOLLOW UP; GENERAL PRACTITIONER; HORMONAL THERAPY; HOSPITAL DISCHARGE; HUMAN; INTERPERSONAL COMMUNICATION; LYMPHEDEMA; MANAGED CARE; MEDICAL INFORMATION; MEDICAL SPECIALIST; ONCOLOGY; ONLINE SYSTEM; PATIENT COUNSELING; PRACTICE GUIDELINE; PROFESSIONAL KNOWLEDGE; PSYCHOSOCIAL CARE; QUESTIONNAIRE;

EID: 80053654178     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.v18i5.793     Document Type: Article

References (35)

1. Canadian Cancer Society. Home > Canada Wide > About Cancer > Cancer Statistics > Statistics at a Glance > Breast Cancer Statistics [Web resource]. Toronto, ON: Canadian Cancer Society; 2010. [Available online at: http://www.cancer.ca/Canada-wide/About%20cancer/Cancer%20statistics/Stats%20at%20a%20glance/Breast%20cancer.aspx?sc_lang=en; citedAugust 19, 2010]
2. Burstein HJ, Winer EP. Primary care for survivors of breast cancer. N Engl J Med 2000;343:1086-94.
3. Yabroff KR, Lawrence WF, Clauser S, Davis WW, Brown ML. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst 2004;96:1322-30.
4. The Systemic Therapy Task Force. Systemic Therapy Task Force Report. Toronto, ON: Cancer Care Ontario; 2000.
5. Grunfeld E, Earle CC. The interface between primary and oncology specialty care: treatment through survivorship. J Natl Cancer Inst Monogr 2010;2010:25-30.
6. Hewitt M, Greenfield S, Stovall E, eds. From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC: The National Academies Press; 2005.
7. Hewitt ME, Bamundo A, Day R, Harvey C. Perspectives on post-treatment cancer care: qualitative research with survivors, nurses, and physicians. J Clin Oncol 2007;25:2270-3.
8. Cheung WY, Neville BA, Cameron DB, Cook EF, Earle CC. Comparisons of patient and physician expectations for cancer survivorship care. J Clin Oncol 2009;27:2489-95.
9. American Society of Clinical Oncology (ASCO). ASCO Cancer Treatment Summaries [Web page]. Alexandria, VA: ASCO; n.d. [Available online at: http://www.cancer.net/patient/Survivorship/ASCO+Cancer+Treatment+Summaries; cited January 2011]
10. Nissen MJ, Beran MS, Lee MW, Mehta SR, Pine DA, Swenson KK. Views of primary care providers on follow-up care of cancer patients. Fam Med 2007;39:477-82.
11. Del Giudice ME, Grunfeld E, Harvey BJ, Piliotis E, Verma S. Primary care physicians' views of routine follow-up care of cancer survivors. J Clin Oncol 2009;27:3338-45.
12. Grunfeld E, Mant D, Yudkin P, et al. Routine follow-up of breast cancer in primary care: a randomized trial. BMJ 1996;313:665-9.
13. Grunfeld E, Levine MN, Julian JA, et al. A randomized trial of long term follow-up for early stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol 2006;24:848-55.
14. Mao JJ, Bowman MA, Stricker CT, et al. Delivery of survivorship care by primary care physicians: the perspective of breast cancer patients. J Clin Oncol 2009;27:933-8.
15. Grunfeld E, Fitzpatrick R, Mant D, et al. Comparison of breast cancer patient satisfaction with follow-up in primary care versus specialist care: results from a randomized controlled trial. Br J Gen Pract 1999;49:705-10.
16. Wood ML. Communication between cancer specialists and family doctors. Can Fam Physician 1993;39:49-57.
17. Earle CC, Neville BA. Under use of necessary care among cancer survivors. Cancer 2004;101:1712-19.
18. Earle CC, Burstein HJ, Winer EP, Weeks JC. Quality of nonbreast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol 2003;21:1447-51.
19. de Bock GH, Bonnema J, Zwaan RE, van de Velde CJ, Kievit J, Stiggelbout AM. Patient's needs and preferences in routine follow-up after treatment for breast cancer. Br J Cancer 2004;90:1144-50.
20. Grunfeld E, Dhesy-Thind S, Levine M on behalf of the Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update). CMAJ 2005;172:1319-20.
21. Barnes EA, Hanson J, Neumann CM, Nekolaichuk CL, Bruera E. Communication between primary care physicians and radiation oncologists regarding patients with cancer treated with palliative radiotherapy. J Clin Oncol 2000;18:2902-7.
22. Dworkind M, Towers A, Murnaghan D, Guibert R, Iverson D. Communication between family physicians and oncologists: qualitative results of an exploratory study. Cancer Prev Control 1999;3:137-44.
23. Khatcheressian JL, Wolff AC, Smith TJ, et al. on behalf of American Society of Clinical Oncology. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 2006;24:5091-7.
24. Dillman DA. Mail and Internet Surveys: The Tailored Design Method. 2nd ed. New York, NY: Wiley; 2000.
25. Ferrell BR, Winn R. Medical and nursing education and training opportunities to improve survivorship care. J Clin Oncol 2006;24:5142-8.
26. Sussman J, Baldwin LM. The interface of primary and oncology specialty care: from diagnosis through primary treatment. J Natl Cancer Inst Monogr 2010;2010:18-24.
27. Fennell ML, Das IP, Clauser S, Petrelli N, Salner A. The organization of multidisciplinary care teams: modeling internal and external influences on cancer care quality. J Natl Cancer Inst Monogr 2010;2010:72-80.
28. Goss PE, Ingle JN, Martino S, et al. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 2003;349:1793-802.
29. Howell A, Cuzick J, Baum M, et al. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 2005;365:60-2.
30. Thürlimann B, Keshaviah A, Coates AS, et al. on behalf of the Breast International Group (BIG) 1-98 Collaborative Group. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 2005;353:2747-57.
31. Coates AS, Keshaviah A, Thürlimann B, et al. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. J Clin Oncol 2007;25:486-92.
32. Coombes RC, Kilburn LS, Snowdon CF, et al. Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomized controlled trial. Lancet 2007;369:559-70.
33. Forbes JF, Cuzick J, Buzdar A, et al. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol 2008;9:45-53.
34. van Walraven C, Duke SM, Weinberg AL, Wells PS. Standardized or narrative discharge summaries. Which do family physicians prefer? Can Fam Physician 1998;44:62-9.
35. Braun TC, Hagen NA, Smith C, Summers N. Oncologists and family physicians. Using a standardized letter to improve communication. Can Fam Physician 2003;49:882-6.